Physician profile
Andrew Lee
NPI 1336536861
$2,972.11
in general payments reported to CMS, 2019-2025
20 companies · $326 in 2025
The $326 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $149 · 2020: $249 · 2021: $388 · 2022: $848 · 2023: $244 · 2024: $769 · 2025: $326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,310 · Entertainment: $28.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,310.24 |
| Entertainment | $28.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $881.43 | 2022-2025 | |
| Sun Pharmaceutical Industries INC. | $328.66 | 2021-2024 | |
| Allergan, INC. | $278.59 | 2020-2022 | |
| Alcon Vision LLC | $224.01 | 2022-2024 | Clareon, Argos |
| Oyster Point Pharma, INC. | $204.63 | 2022-2025 | Tyrvaya, Ryzumvi |
| Boston Scientific Corporation | $183.95 | 2023-2024 | Emerge Push, Bodyguardian |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $162.14 | 2019-2020 | |
| Aerie Pharmaceuticals, INC. | $122.48 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $113.90 | 2020-2022 | |
| Amgen INC. | $99.30 | 2024 | Tepezza |
| Eyevance Pharmaceuticals LLC | $74.01 | 2020-2022 | |
| Sight Sciences, INC. | $71.71 | 2021-2022 | |
| Horizon Therapeutics Plc | $69.44 | 2022 | |
| Dentsply Sirona INC | $34.75 | 2025 | Suresmile |
| Optos, INC. | $28.39 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $24.06 | 2021 | |
| Kala Pharmaceuticals, INC. | $19.78 | 2022 | |
| Rxsight INC | $19.30 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Tearlab Corp | $18.70 | 2021 | |
| Bausch & Lomb Americas INC. | $12.88 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.